1-20 of 150
Sort by
News

Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML

Leah Lawrence
Published: 2023
Abstract
December 2023
View News titled, Magrolimab/Azacitidine Combo Shows Efficacy for Untreated TP53-Mutant AML
News

HLA-Haploidentical Transplantation in Pediatric Acute Leukemia Offers Alternative to Matched Donor

Deborah Levenson
Published: 2023
Abstract
December 2023
View News titled, HLA-Haploidentical Transplantation in Pediatric Acute Leukemia Offers Alternative to Matched Donor
News

TP53 Status May Hint at Acute Myeloid Leukemia Prognosis

Lara C. Pullen, PhD
Published: 2023
Abstract
Mid-November 2023
View News titled, TP53 Status May Hint at Acute Myeloid Leukemia Prognosis
News

Children With T-ALL Show Similar Treatment Outcomes Independent of ETP Status

Katie Robinson
Published: 2023
Abstract
November 2023
View News titled, Children With T-ALL Show Similar Treatment Outcomes Independent of ETP Status
News

RT-qPCR MRD-Negativity Prognostic for NPM1-mutated Acute Myeloid Leukemia

Leah Lawrence
Published: 2023
Abstract
November 2023
View News titled, RT-qPCR MRD-Negativity Prognostic for NPM1-mutated Acute Myeloid Leukemia
News

Vitamin C, D Supplementation Benefits Patients with Acute Myeloid Leukemia

Lara C. Pullen, PhD
Published: 2023
Abstract
November 2023
View News titled, Vitamin C, D Supplementation Benefits Patients with Acute Myeloid Leukemia
News

Venetoclax Reverses Negative Prognostic Impact of Splicing Factor Mutations for Patients with Acute Myeloid Leukemia

Anna Azvolinsky, PhD
Published: 2023
Abstract
October 2023
View News titled, Venetoclax Reverses Negative Prognostic Impact of Splicing Factor Mutations for Patients with Acute Myeloid Leukemia
News

Non-Chemo Sequential Therapy Achieves High Remission in Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia

Anna Azvolinsky, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Non-Chemo Sequential Therapy Achieves High Remission in Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
News

Menin Inhibitor Revumenib Produces Strong Responses in R/R KMT2A-Rearranged Leukemia

Thomas R. Collins
Published: 2023
Abstract
July 2023
View News titled, Menin Inhibitor Revumenib Produces Strong Responses in R/R KMT2A-Rearranged Leukemia
News

Integrated Care, Wider Donor Sources Can Boost Transplant Access for Patients With AL, MDS

Thomas R. Collins
Published: 2023
Abstract
July 2023
View News titled, Integrated Care, Wider Donor Sources Can Boost Transplant Access for Patients With AL, MDS
News

Non-Chemotherapy Sequential Therapy Achieves High Remission Rate Among Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia

Anna Azvolinsky, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Non-Chemotherapy Sequential Therapy Achieves High Remission Rate Among Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
News

Non-Chemotherapy, Sequential Combination Regimen Tested in Older Patients with B-cell Acute Lymphoblastic Leukemia

Anna Azvolinsky, PhD
Published: 2023
Abstract
Mid-July 2023
View News titled, Non-Chemotherapy, Sequential Combination Regimen Tested in Older Patients with B-cell Acute Lymphoblastic Leukemia
News

2022 ELN Genetic-Risk Stratification Does Not Predict Outcomes Better Than 2017 Stratification for Adults With AML

Khylia Marshall
Published: 2023
Abstract
June 2023
View News titled, 2022 ELN Genetic-Risk Stratification Does Not Predict Outcomes Better Than 2017 Stratification for Adults With AML
News

Telehealth Advanced Care Planning Conversations Benefit Older Patients With AML, MDS

Anna Azvolinsky, PhD
Published: 2023
Abstract
March 2023
View News titled, Telehealth Advanced Care Planning Conversations Benefit Older Patients With AML, MDS
News

Updated 2022 ELN Guidelines Better Stratify Patients With AML Treated With IC

Khylia Marshall
Published: 2023
Abstract
February 2023
View News titled, Updated 2022 ELN Guidelines Better Stratify Patients With AML Treated With IC
News

IDH Inhibitor Olutasidenib Active With or Without Azacitidine in IDH1-Mutated AML

Leah Lawrence
Published: 2023
Abstract
February 2023
View News titled, IDH Inhibitor Olutasidenib Active With or Without Azacitidine in IDH1-Mutated AML
News

Intensive Chemotherapy Before alloHCT Does Not Improve Survival in AML

Leah Lawrence
Published: 2022
View News titled, Intensive Chemotherapy Before alloHCT Does Not Improve Survival in AML
News

CAR T-Cell Therapy May Help Mitigate Disparities in Pediatric ALL

Lara C. Pullen, PhD
Published: 2022
Abstract
December 2022
View News titled, CAR T-Cell Therapy May Help Mitigate Disparities in Pediatric ALL
News

Co-mutation Patterns Allowed for Updated Risk Stratification of NPM1-Mutated AML

Leah Lawrence
Published: 2022
Abstract
Mid-January 2023
View News titled, Co-mutation Patterns Allowed for Updated Risk Stratification of NPM1-Mutated AML
News

Reduced Venetoclax Exposure With Azacitidine Appears Feasible in Treatment-Naïve AML

Brandon May
Published: 2022
Abstract
Mid-January 2023
View News titled, Reduced Venetoclax Exposure With Azacitidine Appears Feasible in Treatment-Naïve AML